nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—hypertension—type 2 diabetes mellitus	0.441	1	CtDrD
Fenoldopam—ADRA2A—type 2 diabetes mellitus	0.169	1	CbGaD
Fenoldopam—DRD5—Bromocriptine—type 2 diabetes mellitus	0.06	0.225	CbGbCtD
Fenoldopam—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0338	0.126	CbGbCtD
Fenoldopam—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0307	0.115	CbGbCtD
Fenoldopam—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0307	0.115	CbGbCtD
Fenoldopam—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0291	0.109	CbGbCtD
Fenoldopam—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0246	0.092	CbGbCtD
Fenoldopam—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0202	0.0757	CbGbCtD
Fenoldopam—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0194	0.0726	CbGbCtD
Fenoldopam—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0186	0.0698	CbGbCtD
Fenoldopam—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.00023	0.00346	CcSEcCtD
Fenoldopam—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00343	CcSEcCtD
Fenoldopam—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.000227	0.00342	CcSEcCtD
Fenoldopam—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000227	0.00342	CcSEcCtD
Fenoldopam—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000227	0.00342	CcSEcCtD
Fenoldopam—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.000226	0.0034	CcSEcCtD
Fenoldopam—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000225	0.00339	CcSEcCtD
Fenoldopam—Angina pectoris—Metformin—type 2 diabetes mellitus	0.000225	0.00339	CcSEcCtD
Fenoldopam—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000225	0.00339	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.000225	0.00339	CcSEcCtD
Fenoldopam—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000224	0.00337	CcSEcCtD
Fenoldopam—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.000224	0.00337	CcSEcCtD
Fenoldopam—Blood creatinine increased—Losartan—type 2 diabetes mellitus	0.000223	0.00335	CcSEcCtD
Fenoldopam—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000222	0.00335	CcSEcCtD
Fenoldopam—Anxiety—Glimepiride—type 2 diabetes mellitus	0.000221	0.00332	CcSEcCtD
Fenoldopam—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00331	CcSEcCtD
Fenoldopam—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.00022	0.00331	CcSEcCtD
Fenoldopam—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000218	0.00328	CcSEcCtD
Fenoldopam—Urinary tract infection—Orlistat—type 2 diabetes mellitus	0.000217	0.00328	CcSEcCtD
Fenoldopam—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000217	0.00327	CcSEcCtD
Fenoldopam—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000217	0.00327	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000217	0.00327	CcSEcCtD
Fenoldopam—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000215	0.00324	CcSEcCtD
Fenoldopam—Headache—Tolazamide—type 2 diabetes mellitus	0.000215	0.00324	CcSEcCtD
Fenoldopam—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.000213	0.0032	CcSEcCtD
Fenoldopam—Headache—Linagliptin—type 2 diabetes mellitus	0.000213	0.0032	CcSEcCtD
Fenoldopam—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000211	0.00317	CcSEcCtD
Fenoldopam—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00021	0.00316	CcSEcCtD
Fenoldopam—Vomiting—Acarbose—type 2 diabetes mellitus	0.000209	0.00315	CcSEcCtD
Fenoldopam—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.000209	0.00315	CcSEcCtD
Fenoldopam—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000207	0.00312	CcSEcCtD
Fenoldopam—Insomnia—Glipizide—type 2 diabetes mellitus	0.000206	0.0031	CcSEcCtD
Fenoldopam—Flushing—Gliclazide—type 2 diabetes mellitus	0.000205	0.00309	CcSEcCtD
Fenoldopam—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000205	0.00309	CcSEcCtD
Fenoldopam—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000204	0.00308	CcSEcCtD
Fenoldopam—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000204	0.00307	CcSEcCtD
Fenoldopam—Nausea—Tolazamide—type 2 diabetes mellitus	0.000204	0.00307	CcSEcCtD
Fenoldopam—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000203	0.00306	CcSEcCtD
Fenoldopam—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000203	0.00305	CcSEcCtD
Fenoldopam—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000202	0.00304	CcSEcCtD
Fenoldopam—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000202	0.00304	CcSEcCtD
Fenoldopam—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000201	0.00303	CcSEcCtD
Fenoldopam—Angina pectoris—Losartan—type 2 diabetes mellitus	0.0002	0.00301	CcSEcCtD
Fenoldopam—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000199	0.003	CcSEcCtD
Fenoldopam—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000198	0.00299	CcSEcCtD
Fenoldopam—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000197	0.00297	CcSEcCtD
Fenoldopam—Nausea—Acarbose—type 2 diabetes mellitus	0.000196	0.00295	CcSEcCtD
Fenoldopam—Constipation—Glipizide—type 2 diabetes mellitus	0.000194	0.00293	CcSEcCtD
Fenoldopam—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000194	0.00293	CcSEcCtD
Fenoldopam—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000192	0.00289	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000192	0.00289	CcSEcCtD
Fenoldopam—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000191	0.00288	CcSEcCtD
Fenoldopam—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.000191	0.00288	CcSEcCtD
Fenoldopam—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000191	0.00287	CcSEcCtD
Fenoldopam—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000189	0.00285	CcSEcCtD
Fenoldopam—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000189	0.00285	CcSEcCtD
Fenoldopam—Tension—Gliclazide—type 2 diabetes mellitus	0.000189	0.00285	CcSEcCtD
Fenoldopam—Nausea—Nateglinide—type 2 diabetes mellitus	0.000189	0.00284	CcSEcCtD
Fenoldopam—Bradycardia—Metformin—type 2 diabetes mellitus	0.000188	0.00284	CcSEcCtD
Fenoldopam—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000188	0.00283	CcSEcCtD
Fenoldopam—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000187	0.00282	CcSEcCtD
Fenoldopam—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00282	CcSEcCtD
Fenoldopam—Back pain—Gliclazide—type 2 diabetes mellitus	0.000186	0.00281	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000186	0.0028	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000186	0.0028	CcSEcCtD
Fenoldopam—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00273	CcSEcCtD
Fenoldopam—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00018	0.00271	CcSEcCtD
Fenoldopam—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000179	0.0027	CcSEcCtD
Fenoldopam—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000178	0.00268	CcSEcCtD
Fenoldopam—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000178	0.00268	CcSEcCtD
Fenoldopam—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000178	0.00268	CcSEcCtD
Fenoldopam—Sweating—Losartan—type 2 diabetes mellitus	0.000176	0.00264	CcSEcCtD
Fenoldopam—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000175	0.00263	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000174	0.00261	CcSEcCtD
Fenoldopam—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00261	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00261	CcSEcCtD
Fenoldopam—Headache—Repaglinide—type 2 diabetes mellitus	0.000172	0.00259	CcSEcCtD
Fenoldopam—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000172	0.00259	CcSEcCtD
Fenoldopam—Flushing—Metformin—type 2 diabetes mellitus	0.000172	0.00259	CcSEcCtD
Fenoldopam—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000172	0.00258	CcSEcCtD
Fenoldopam—Back pain—Valsartan—type 2 diabetes mellitus	0.000171	0.00258	CcSEcCtD
Fenoldopam—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00257	CcSEcCtD
Fenoldopam—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00017	0.00256	CcSEcCtD
Fenoldopam—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.00017	0.00256	CcSEcCtD
Fenoldopam—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000169	0.00255	CcSEcCtD
Fenoldopam—Back pain—Orlistat—type 2 diabetes mellitus	0.000169	0.00255	CcSEcCtD
Fenoldopam—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000168	0.00253	CcSEcCtD
Fenoldopam—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000168	0.00253	CcSEcCtD
Fenoldopam—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000167	0.00252	CcSEcCtD
Fenoldopam—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000164	0.00247	CcSEcCtD
Fenoldopam—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000164	0.00247	CcSEcCtD
Fenoldopam—Hypotension—Glyburide—type 2 diabetes mellitus	0.000164	0.00246	CcSEcCtD
Fenoldopam—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000163	0.00246	CcSEcCtD
Fenoldopam—Nausea—Repaglinide—type 2 diabetes mellitus	0.000163	0.00246	CcSEcCtD
Fenoldopam—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000163	0.00245	CcSEcCtD
Fenoldopam—Flushing—Irbesartan—type 2 diabetes mellitus	0.000162	0.00244	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00236	CcSEcCtD
Fenoldopam—Palpitations—Valsartan—type 2 diabetes mellitus	0.000156	0.00236	CcSEcCtD
Fenoldopam—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000156	0.00235	CcSEcCtD
Fenoldopam—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000156	0.00234	CcSEcCtD
Fenoldopam—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000155	0.00233	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000155	0.00233	CcSEcCtD
Fenoldopam—Palpitations—Orlistat—type 2 diabetes mellitus	0.000154	0.00233	CcSEcCtD
Fenoldopam—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000154	0.00232	CcSEcCtD
Fenoldopam—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000154	0.00232	CcSEcCtD
Fenoldopam—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000153	0.00231	CcSEcCtD
Fenoldopam—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000153	0.0023	CcSEcCtD
Fenoldopam—Flushing—Losartan—type 2 diabetes mellitus	0.000153	0.0023	CcSEcCtD
Fenoldopam—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000152	0.00229	CcSEcCtD
Fenoldopam—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00228	CcSEcCtD
Fenoldopam—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00228	CcSEcCtD
Fenoldopam—Chest pain—Valsartan—type 2 diabetes mellitus	0.000151	0.00227	CcSEcCtD
Fenoldopam—Sweating—Ramipril—type 2 diabetes mellitus	0.000151	0.00227	CcSEcCtD
Fenoldopam—Dizziness—Glipizide—type 2 diabetes mellitus	0.00015	0.00227	CcSEcCtD
Fenoldopam—Anxiety—Valsartan—type 2 diabetes mellitus	0.00015	0.00226	CcSEcCtD
Fenoldopam—Tension—Irbesartan—type 2 diabetes mellitus	0.000149	0.00225	CcSEcCtD
Fenoldopam—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000149	0.00225	CcSEcCtD
Fenoldopam—Chest pain—Orlistat—type 2 diabetes mellitus	0.000149	0.00224	CcSEcCtD
Fenoldopam—Anxiety—Orlistat—type 2 diabetes mellitus	0.000148	0.00223	CcSEcCtD
Fenoldopam—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000148	0.00222	CcSEcCtD
Fenoldopam—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000147	0.00221	CcSEcCtD
Fenoldopam—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000146	0.0022	CcSEcCtD
Fenoldopam—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000145	0.00219	CcSEcCtD
Fenoldopam—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000145	0.00218	CcSEcCtD
Fenoldopam—Vomiting—Glipizide—type 2 diabetes mellitus	0.000145	0.00218	CcSEcCtD
Fenoldopam—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000144	0.00217	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000143	0.00216	CcSEcCtD
Fenoldopam—Headache—Glipizide—type 2 diabetes mellitus	0.000142	0.00215	CcSEcCtD
Fenoldopam—Palpitations—Metformin—type 2 diabetes mellitus	0.000142	0.00215	CcSEcCtD
Fenoldopam—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000142	0.00214	CcSEcCtD
Fenoldopam—Tension—Losartan—type 2 diabetes mellitus	0.00014	0.00212	CcSEcCtD
Fenoldopam—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00014	0.00211	CcSEcCtD
Fenoldopam—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00014	0.00211	CcSEcCtD
Fenoldopam—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00211	CcSEcCtD
Fenoldopam—Nervousness—Losartan—type 2 diabetes mellitus	0.000139	0.00209	CcSEcCtD
Fenoldopam—Back pain—Losartan—type 2 diabetes mellitus	0.000138	0.00209	CcSEcCtD
Fenoldopam—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000138	0.00208	CcSEcCtD
Fenoldopam—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000138	0.00208	CcSEcCtD
Fenoldopam—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000138	0.00207	CcSEcCtD
Fenoldopam—Chest pain—Metformin—type 2 diabetes mellitus	0.000137	0.00207	CcSEcCtD
Fenoldopam—Headache—Pioglitazone—type 2 diabetes mellitus	0.000136	0.00206	CcSEcCtD
Fenoldopam—Nausea—Glipizide—type 2 diabetes mellitus	0.000135	0.00204	CcSEcCtD
Fenoldopam—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000135	0.00203	CcSEcCtD
Fenoldopam—Hypotension—Valsartan—type 2 diabetes mellitus	0.000135	0.00203	CcSEcCtD
Fenoldopam—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000135	0.00203	CcSEcCtD
Fenoldopam—Constipation—Gliclazide—type 2 diabetes mellitus	0.000134	0.00202	CcSEcCtD
Fenoldopam—Headache—Glimepiride—type 2 diabetes mellitus	0.000133	0.002	CcSEcCtD
Fenoldopam—Headache—Sitagliptin—type 2 diabetes mellitus	0.000133	0.002	CcSEcCtD
Fenoldopam—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000131	0.00197	CcSEcCtD
Fenoldopam—Flushing—Ramipril—type 2 diabetes mellitus	0.000131	0.00197	CcSEcCtD
Fenoldopam—Insomnia—Valsartan—type 2 diabetes mellitus	0.000131	0.00197	CcSEcCtD
Fenoldopam—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000129	0.00195	CcSEcCtD
Fenoldopam—Insomnia—Orlistat—type 2 diabetes mellitus	0.000129	0.00194	CcSEcCtD
Fenoldopam—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000129	0.00194	CcSEcCtD
Fenoldopam—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000129	0.00194	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000129	0.00194	CcSEcCtD
Fenoldopam—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000127	0.00192	CcSEcCtD
Fenoldopam—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000127	0.00191	CcSEcCtD
Fenoldopam—Palpitations—Losartan—type 2 diabetes mellitus	0.000126	0.00191	CcSEcCtD
Fenoldopam—Nausea—Glimepiride—type 2 diabetes mellitus	0.000126	0.0019	CcSEcCtD
Fenoldopam—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000126	0.00189	CcSEcCtD
Fenoldopam—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000124	0.00187	CcSEcCtD
Fenoldopam—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000124	0.00187	CcSEcCtD
Fenoldopam—Constipation—Valsartan—type 2 diabetes mellitus	0.000123	0.00186	CcSEcCtD
Fenoldopam—Hypotension—Metformin—type 2 diabetes mellitus	0.000123	0.00185	CcSEcCtD
Fenoldopam—Chest pain—Losartan—type 2 diabetes mellitus	0.000122	0.00184	CcSEcCtD
Fenoldopam—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00183	CcSEcCtD
Fenoldopam—Anxiety—Losartan—type 2 diabetes mellitus	0.000121	0.00183	CcSEcCtD
Fenoldopam—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000121	0.00182	CcSEcCtD
Fenoldopam—Tension—Ramipril—type 2 diabetes mellitus	0.00012	0.00181	CcSEcCtD
Fenoldopam—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00012	0.00181	CcSEcCtD
Fenoldopam—Headache—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00181	CcSEcCtD
Fenoldopam—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00012	0.0018	CcSEcCtD
Fenoldopam—Nervousness—Ramipril—type 2 diabetes mellitus	0.000119	0.0018	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000118	0.00178	CcSEcCtD
Fenoldopam—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000118	0.00178	CcSEcCtD
Fenoldopam—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000117	0.00177	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000117	0.00176	CcSEcCtD
Fenoldopam—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000116	0.00175	CcSEcCtD
Fenoldopam—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000114	0.00172	CcSEcCtD
Fenoldopam—Tachycardia—Losartan—type 2 diabetes mellitus	0.000114	0.00172	CcSEcCtD
Fenoldopam—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000114	0.00171	CcSEcCtD
Fenoldopam—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000113	0.0017	CcSEcCtD
Fenoldopam—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.0017	CcSEcCtD
Fenoldopam—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000113	0.0017	CcSEcCtD
Fenoldopam—Constipation—Metformin—type 2 diabetes mellitus	0.000112	0.00169	CcSEcCtD
Fenoldopam—Vomiting—Glyburide—type 2 diabetes mellitus	0.000111	0.00168	CcSEcCtD
Fenoldopam—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000111	0.00167	CcSEcCtD
Fenoldopam—Headache—Glyburide—type 2 diabetes mellitus	0.00011	0.00165	CcSEcCtD
Fenoldopam—Hypotension—Losartan—type 2 diabetes mellitus	0.000109	0.00164	CcSEcCtD
Fenoldopam—Palpitations—Ramipril—type 2 diabetes mellitus	0.000108	0.00163	CcSEcCtD
Fenoldopam—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000108	0.00162	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000108	0.00162	CcSEcCtD
Fenoldopam—Constipation—Irbesartan—type 2 diabetes mellitus	0.000106	0.0016	CcSEcCtD
Fenoldopam—Insomnia—Losartan—type 2 diabetes mellitus	0.000106	0.00159	CcSEcCtD
Fenoldopam—Chest pain—Ramipril—type 2 diabetes mellitus	0.000104	0.00157	CcSEcCtD
Fenoldopam—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000104	0.00157	CcSEcCtD
Fenoldopam—Anxiety—Ramipril—type 2 diabetes mellitus	0.000104	0.00157	CcSEcCtD
Fenoldopam—Nausea—Glyburide—type 2 diabetes mellitus	0.000104	0.00157	CcSEcCtD
Fenoldopam—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000104	0.00157	CcSEcCtD
Fenoldopam—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000104	0.00157	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.00153	CcSEcCtD
Fenoldopam—Vomiting—Gliclazide—type 2 diabetes mellitus	9.99e-05	0.00151	CcSEcCtD
Fenoldopam—Constipation—Losartan—type 2 diabetes mellitus	9.99e-05	0.0015	CcSEcCtD
Fenoldopam—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.88e-05	0.00149	CcSEcCtD
Fenoldopam—Headache—Gliclazide—type 2 diabetes mellitus	9.85e-05	0.00148	CcSEcCtD
Fenoldopam—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.00148	CcSEcCtD
Fenoldopam—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.00148	CcSEcCtD
Fenoldopam—Tachycardia—Ramipril—type 2 diabetes mellitus	9.77e-05	0.00147	CcSEcCtD
Fenoldopam—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.76e-05	0.00147	CcSEcCtD
Fenoldopam—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.68e-05	0.00146	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.55e-05	0.00144	CcSEcCtD
Fenoldopam—Dizziness—Valsartan—type 2 diabetes mellitus	9.55e-05	0.00144	CcSEcCtD
Fenoldopam—Dizziness—Orlistat—type 2 diabetes mellitus	9.43e-05	0.00142	CcSEcCtD
Fenoldopam—Hypotension—Ramipril—type 2 diabetes mellitus	9.36e-05	0.00141	CcSEcCtD
Fenoldopam—Nausea—Gliclazide—type 2 diabetes mellitus	9.33e-05	0.00141	CcSEcCtD
Fenoldopam—Body temperature increased—Losartan—type 2 diabetes mellitus	9.23e-05	0.00139	CcSEcCtD
Fenoldopam—Abdominal pain—Losartan—type 2 diabetes mellitus	9.23e-05	0.00139	CcSEcCtD
Fenoldopam—Vomiting—Valsartan—type 2 diabetes mellitus	9.18e-05	0.00138	CcSEcCtD
Fenoldopam—Vomiting—Orlistat—type 2 diabetes mellitus	9.07e-05	0.00137	CcSEcCtD
Fenoldopam—Insomnia—Ramipril—type 2 diabetes mellitus	9.06e-05	0.00136	CcSEcCtD
Fenoldopam—Headache—Valsartan—type 2 diabetes mellitus	9.05e-05	0.00136	CcSEcCtD
Fenoldopam—Diarrhoea—Metformin—type 2 diabetes mellitus	9e-05	0.00136	CcSEcCtD
Fenoldopam—Headache—Orlistat—type 2 diabetes mellitus	8.94e-05	0.00135	CcSEcCtD
Fenoldopam—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.93e-05	0.00134	CcSEcCtD
Fenoldopam—Dizziness—Metformin—type 2 diabetes mellitus	8.69e-05	0.00131	CcSEcCtD
Fenoldopam—Nausea—Valsartan—type 2 diabetes mellitus	8.58e-05	0.00129	CcSEcCtD
Fenoldopam—Constipation—Ramipril—type 2 diabetes mellitus	8.56e-05	0.00129	CcSEcCtD
Fenoldopam—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.00128	CcSEcCtD
Fenoldopam—Nausea—Orlistat—type 2 diabetes mellitus	8.47e-05	0.00128	CcSEcCtD
Fenoldopam—Vomiting—Metformin—type 2 diabetes mellitus	8.36e-05	0.00126	CcSEcCtD
Fenoldopam—Headache—Metformin—type 2 diabetes mellitus	8.24e-05	0.00124	CcSEcCtD
Fenoldopam—Dizziness—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.00124	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.19e-05	0.00123	CcSEcCtD
Fenoldopam—Diarrhoea—Losartan—type 2 diabetes mellitus	7.99e-05	0.0012	CcSEcCtD
Fenoldopam—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.92e-05	0.00119	CcSEcCtD
Fenoldopam—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.92e-05	0.00119	CcSEcCtD
Fenoldopam—Vomiting—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.00119	CcSEcCtD
Fenoldopam—Nausea—Metformin—type 2 diabetes mellitus	7.81e-05	0.00118	CcSEcCtD
Fenoldopam—Headache—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.00117	CcSEcCtD
Fenoldopam—Dizziness—Losartan—type 2 diabetes mellitus	7.72e-05	0.00116	CcSEcCtD
Fenoldopam—Vomiting—Losartan—type 2 diabetes mellitus	7.42e-05	0.00112	CcSEcCtD
Fenoldopam—Nausea—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.00111	CcSEcCtD
Fenoldopam—Headache—Losartan—type 2 diabetes mellitus	7.32e-05	0.0011	CcSEcCtD
Fenoldopam—Nausea—Losartan—type 2 diabetes mellitus	6.94e-05	0.00105	CcSEcCtD
Fenoldopam—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.85e-05	0.00103	CcSEcCtD
Fenoldopam—Dizziness—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000998	CcSEcCtD
Fenoldopam—Vomiting—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000959	CcSEcCtD
Fenoldopam—Headache—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000945	CcSEcCtD
Fenoldopam—Nausea—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000896	CcSEcCtD
Fenoldopam—ADRA2C—Signaling Pathways—AGT—type 2 diabetes mellitus	2.74e-06	4.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—AKT1—type 2 diabetes mellitus	2.73e-06	4.86e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.73e-06	4.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.72e-06	4.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—INS—type 2 diabetes mellitus	2.72e-06	4.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.71e-06	4.84e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.71e-06	4.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.71e-06	4.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.71e-06	4.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.7e-06	4.82e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	2.7e-06	4.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.69e-06	4.81e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SRC—type 2 diabetes mellitus	2.69e-06	4.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—LEP—type 2 diabetes mellitus	2.68e-06	4.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APOE—type 2 diabetes mellitus	2.68e-06	4.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.68e-06	4.78e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.68e-06	4.78e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.68e-06	4.77e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.67e-06	4.76e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.66e-06	4.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	2.66e-06	4.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.65e-06	4.73e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.65e-06	4.73e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.65e-06	4.73e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	2.64e-06	4.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	2.64e-06	4.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.63e-06	4.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.63e-06	4.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.63e-06	4.69e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.62e-06	4.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.62e-06	4.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-06	4.67e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	2.62e-06	4.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.61e-06	4.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	2.61e-06	4.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.6e-06	4.64e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.58e-06	4.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-06	4.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.56e-06	4.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.55e-06	4.54e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.53e-06	4.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.53e-06	4.52e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	2.52e-06	4.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ALB—type 2 diabetes mellitus	2.51e-06	4.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.5e-06	4.46e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.5e-06	4.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.49e-06	4.44e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.49e-06	4.44e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.49e-06	4.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	2.46e-06	4.38e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.44e-06	4.36e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.44e-06	4.35e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.44e-06	4.35e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.44e-06	4.35e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.42e-06	4.31e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.42e-06	4.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.42e-06	4.31e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.41e-06	4.3e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.41e-06	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3R1—type 2 diabetes mellitus	2.41e-06	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—NOS3—type 2 diabetes mellitus	2.41e-06	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.4e-06	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.4e-06	4.28e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.4e-06	4.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.4e-06	4.27e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.4e-06	4.27e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.39e-06	4.25e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.39e-06	4.25e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.38e-06	4.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.37e-06	4.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.36e-06	4.22e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.36e-06	4.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.36e-06	4.2e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.36e-06	4.2e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.35e-06	4.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.35e-06	4.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	2.34e-06	4.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.32e-06	4.14e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.3e-06	4.1e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—INS—type 2 diabetes mellitus	2.29e-06	4.09e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.28e-06	4.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	2.27e-06	4.05e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	2.26e-06	4.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.26e-06	4.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.26e-06	4.02e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	2.24e-06	4e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.23e-06	3.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.23e-06	3.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	2.23e-06	3.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.23e-06	3.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.22e-06	3.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.22e-06	3.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.22e-06	3.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	2.22e-06	3.95e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.21e-06	3.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.21e-06	3.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	2.2e-06	3.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.19e-06	3.9e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.18e-06	3.89e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.18e-06	3.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.18e-06	3.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.18e-06	3.89e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.17e-06	3.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.17e-06	3.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.16e-06	3.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.15e-06	3.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.15e-06	3.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.11e-06	3.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.09e-06	3.73e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	2.08e-06	3.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.07e-06	3.7e-05	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.07e-06	3.69e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.06e-06	3.67e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.05e-06	3.66e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.05e-06	3.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.04e-06	3.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	2.04e-06	3.64e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.04e-06	3.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.03e-06	3.62e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.02e-06	3.61e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.01e-06	3.59e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.01e-06	3.59e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.01e-06	3.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.01e-06	3.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.01e-06	3.59e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.01e-06	3.58e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2e-06	3.57e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.98e-06	3.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.98e-06	3.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.97e-06	3.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.95e-06	3.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.95e-06	3.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.95e-06	3.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.94e-06	3.46e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.94e-06	3.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.94e-06	3.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.93e-06	3.44e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.92e-06	3.42e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.91e-06	3.41e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.91e-06	3.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.89e-06	3.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.89e-06	3.38e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.88e-06	3.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.86e-06	3.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.86e-06	3.32e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.86e-06	3.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.85e-06	3.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.84e-06	3.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.83e-06	3.27e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.83e-06	3.26e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.83e-06	3.26e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.83e-06	3.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.82e-06	3.24e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.81e-06	3.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.8e-06	3.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.8e-06	3.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.79e-06	3.2e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.79e-06	3.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	3.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.76e-06	3.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.76e-06	3.14e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.76e-06	3.14e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.74e-06	3.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.73e-06	3.08e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.72e-06	3.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.72e-06	3.06e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.72e-06	3.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.71e-06	3.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.71e-06	3.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.71e-06	3.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.7e-06	3.03e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.7e-06	3.03e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.68e-06	3e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.68e-06	2.99e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.67e-06	2.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.67e-06	2.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.66e-06	2.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.63e-06	2.91e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.63e-06	2.91e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.61e-06	2.88e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.6e-06	2.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.6e-06	2.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.59e-06	2.84e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.59e-06	2.83e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.58e-06	2.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.57e-06	2.8e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.57e-06	2.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-06	2.79e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.56e-06	2.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.55e-06	2.77e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.55e-06	2.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.55e-06	2.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.54e-06	2.75e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.54e-06	2.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.54e-06	2.74e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.51e-06	2.69e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.49e-06	2.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.49e-06	2.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.48e-06	2.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.46e-06	2.61e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.46e-06	2.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.45e-06	2.58e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.45e-06	2.58e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.43e-06	2.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.42e-06	2.54e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.42e-06	2.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.41e-06	2.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.4e-06	2.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.4e-06	2.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.4e-06	2.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.39e-06	2.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.38e-06	2.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.37e-06	2.44e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.35e-06	2.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.33e-06	2.37e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.31e-06	2.35e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.31e-06	2.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.31e-06	2.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.3e-06	2.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.3e-06	2.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-06	2.31e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.28e-06	2.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.27e-06	2.27e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.27e-06	2.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.21e-06	2.16e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.21e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.2e-06	2.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.19e-06	2.12e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-06	2.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-06	2.1e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	2.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.14e-06	2.03e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.11e-06	1.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	1.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	1.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-06	1.93e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.07e-06	1.91e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-06	1.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1e-06	1.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.9e-07	1.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.86e-07	1.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.25e-07	1.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.1e-07	1.62e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.09e-07	1.62e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	8.98e-07	1.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.76e-07	1.56e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.39e-07	1.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.14e-07	1.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.08e-07	1.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.51e-07	1.34e-05	CbGpPWpGaD
